📊 Vitals Report – FY25 Financials (Patient: Max Healthcare)
| Metric | FY25 | Change |
|---|---|---|
| Revenue | ₹8,600 Cr | 💉 +20% |
| Net Profit | ₹1,300 Cr | 🏥 +12% |
| EBITDA | ₹2,100 Cr | 💰 +14% |
| EBITDA Margin | 26.2% | 🧪 Slight fever (↓ 1.6pp) |
| Occupancy Rate | 81% | 🛌 Beds full, baby |
| ARPOB | ₹76,100 | 🤑 +2% |
| Max@Home Revenue | ₹212 Cr est. | 👨⚕️ “We now cure you on your couch” |
🏥 Welcome to Max Healthcare — Where Margin is the New Medicine
In a world full of hospitals bleeding red, Max said, “Scalpel? Nah, hand me the P&L statement.” FY25 was all about:
- Filling beds,
- Draining wallets (ethically),
- And acquiring hospitals like you acquire cold in Delhi winters.
🛌 Occupancy & ARPOB: Diagnosis? Full and Expensive
- Occupancy: 81% (up 4%)
- ARPOB: ₹76,100 (up 2%)
- In other words: Even if you came in for a mild fever, you left with a 5-figure bill — and a minty fresh foot massage.
Max didn’t just admit more patients — it extracted more money per bed. Capitalism in its most sanitized form.
🏗️ Expansion Fever: Hospital Ka IPO Ho Gaya?
Max went full land-grab mode:
- ✅ Acquired Jaypee Noida (500 beds)
- ✅ Grabbed Bulandshahr (200 beds)
- ✅ Opened a swanky new 303-bed hospital in Dwarka — because Delhi needed one more reason for ambulance sirens.
This is not hospital expansion. This is Monopoly with ventilators.
🌍 International Revenue = Medical Tourism + Insta Posts
₹700 Cr came from foreigners saying, “Healthcare in India is cheap!”
Max said, “Sure bro, just sign here.”
Now they’re funding profits off hair transplants and heart surgeries from Dubai.
🧪 Max@Home & Max Labs = Max Revenue (No Beds Needed)
- Max@Home: ₹50+ Cr per quarter. You get physio, rehab, critical care — all delivered faster than Swiggy.
- Max Lab: ₹47 Cr from testing your blood while pretending you just needed Vitamin D.
This isn’t just healthcare — this is cashcare.
📉 Margin Droop? Just a Check-Up
Yes, EBITDA margin fell 1.6% but who’s counting when net profit grew 12%?
It’s like losing one chapati from your thali — you still have the rice, dal, gulab jamun, and a giant dividend in the end.
📈 Shareholder MRI: Stock Looking Healthy
| Indicator | Value |
|---|---|
| CMP | ₹650 |
| 52-Week High | ₹680 |
| Gain from Low | +35% |
| Sector Comparison | Better margins than half your IPO portfolio |
Investors be like: “I may not go to a hospital often, but this one deserves my portfolio’s ICU bed.”
🧠 EduInvesting Final Diagnosis
“Max Healthcare is what happens when Apollo has a side hustle and AIIMS gets venture funding.”
- ✅ Consistently growing
- ✅ Scaling smartly
- ✅ Monetizing everything but the hospital gowns
👨⚕️ Prescription for Investors:
- Take 1 tablet of Max Healthcare during every dip.
- Avoid overexposure to pharma stocks with sickly balance sheets.
- Call Max’s management if your P&L needs CPR.
